Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Cancer ; 23(1): 803, 2023 Aug 28.
Article in English | MEDLINE | ID: mdl-37641004

ABSTRACT

BACKGROUND: Cervical cancer represents one of the most prevalent cancers among women worldwide, particularly in low- and middle-income nations. Oncolytic viruses (OVs) can infect cancer cells selectively and lethally without harming normal cells. Respiratory syncytial virus (RSV) is an oncolytic virus for anticancer therapy because of its propensity to multiply within tumor cells. This research aimed to assess the in vitro antitumor activities and molecular basis processes of the oncolytic RSV-A2 on the TC-1 cancer cells as a model for HPV­related cervical cancers. METHODS: Cellular proliferation (MTT) and lactate dehydrogenase (LDH) release assays were used to investigate the catalytic impacts of RSV-A2 by the ELISA method. Real-time PCR and flow cytometry assays were utilized to assess apoptosis, autophagy, intracellular concentrations of reactive oxygen species (ROS), and cell cycle inhibition. RESULTS: Our MTT and LDH results demonstrated that TC-1 cell viability after oncolytic RSV-A2 treatment was MOI-dependently and altered significantly with increasing RSV-A2 virus multiplicity of infection (MOI). Other findings showed that the RSV-A2 potentially resulted in apoptosis and autophagy induction, caspase-3 activation, ROS generation, and cell cycle inhibition in the TC-1 cell line. Real-time PCR assay revealed that RSV-A2 infection significantly elevated the Bax and decreased the Bcl2 expression. CONCLUSIONS: The results indicated that oncolytic RSV-A2 has cytotoxic and inhibiting effects on HPV-associated cervical cancer cells. Our findings revealed that RSV-A2 is a promising treatment candidate for cervical cancer.


Subject(s)
Papillomavirus Infections , Uterine Cervical Neoplasms , Female , Humans , Respiratory Syncytial Viruses , Reactive Oxygen Species , Tumor Necrosis Factor-alpha , bcl-2-Associated X Protein
2.
Virol J ; 19(1): 41, 2022 03 09.
Article in English | MEDLINE | ID: mdl-35264187

ABSTRACT

BACKGROUND: Human pegivirus 1 (HPgV-1) is a Positive-sense single-stranded RNA (+ ssRNA) virus, discovered in 1995 as a Flaviviridae member, and the closest human virus linked to HCV. In comparison to HCV, HPgV-1 seems to be lymphotropic and connected to the viral group that infects T and B lymphocytes. HPgV-1 infection is not persuasively correlated to any known human disease; nevertheless, multiple studies have reported a connection between chronic HPgV-1 infection and improved survival in HPgV-1/HIV co-infected patients with a delayed and favorable impact on HIV infection development. While the process has not been thoroughly clarified, different mechanisms for these observations have been proposed. HPgV-1 is categorized into seven genotypes and various subtypes. Infection with HPgV-1 is relatively common globally. It can be transferred parenterally, sexually, and through vertical ways, and thereby its co-infection with HIV and HCV is common. In most cases, the clearance of HPgV-1 from the body can be achieved by developing E2 antibodies after infection. MAIN BODY: In this review, we thoroughly discuss the current knowledge and recent advances in understanding distinct epidemiological, molecular, and clinical aspects of HPgV-1. CONCLUSION: Due to the unique characteristics of the HPgV-1, so advanced research on HPgV-1, particularly in light of HIV co-infection and other diseases, should be conducted to explore the essential mechanisms of HIV clearance and other viruses and thereby suggest novel strategies for viral therapy in the future.


Subject(s)
Coinfection , Flaviviridae Infections , Flaviviridae , GB virus C , HIV Infections , Hepatitis C , Flaviviridae/genetics , GB virus C/genetics , HIV Infections/complications , Humans , Pegivirus , Phylogeny , RNA, Viral/genetics
4.
Virol J ; 18(1): 201, 2021 10 09.
Article in English | MEDLINE | ID: mdl-34627297

ABSTRACT

BACKGROUND: Several studies on gamma-irradiated influenza A virus (γ-Flu) have revealed its superior efficacy for inducing homologous and heterologous virus-specific immunity. However, many inactivated vaccines, notably in nasal delivery, require adjuvants to increase the quality and magnitude of vaccine responses. METHODS: To illustrate the impacts of co-administration of the gamma-irradiated H1N1 vaccine with poly (I:C) and recombinant murine CCL21, either alone or in combination with each other, as adjuvants on the vaccine potency, mice were inoculated intranasally 3 times at one-week interval with γ-Flu alone or with any of the three adjuvant combinations and then challenged with a high lethal dose (10 LD50) of A/PR/8/34 (H1N1) influenza virus. Virus-specific humoral, mucosal, and cell-mediated immunity, as well as cytokine profiles in the spleen (IFN-γ, IL-12, and IL-4), and in the lung homogenates (IL-6 and IL-10) were measured by ELISA. The proliferative response of restimulated splenocytes was also determined by MTT assay. RESULTS: The findings showed that the co-delivery of the γ-Flu vaccine and CCL21 or Poly (I:C) significantly increased the vaccine immunogenicity compared to the non-adjuvanted vaccine, associated with more potent protection following challenge infection. However, the mice given a combination of CCL21 with poly (I:C) had strong antibody- and cell-mediated immunity, which were considerably higher than responses of mice receiving the γ-Flu vaccine with each adjuvant separately. This combination also reduced inflammatory mediator levels (notably IL-10) in lung homogenate samples. CONCLUSIONS: The results indicate that adjuvantation with the CCL21 and poly (I:C) can successfully induce vigorous vaccine-mediated protection, suggesting a robust propensity for CCL21 plus poly (I:C) as a potent mucosal adjuvant.


Subject(s)
Influenza A Virus, H1N1 Subtype , Influenza Vaccines , Orthomyxoviridae Infections , Adjuvants, Immunologic , Administration, Intranasal , Animals , Antibodies, Viral , Immunity, Cellular , Immunity, Mucosal , Mice , Mice, Inbred BALB C
5.
J Environ Health Sci Eng ; 12(1): 20, 2014 Jan 09.
Article in English | MEDLINE | ID: mdl-24406015

ABSTRACT

Dust storm occurs frequently in arid and semi-arid areas of the world. This natural phenomenon, which is the result of stormy winds, raises a lot of dust from desert surfaces and decreases visibility to less than 1 km. In recent years the temporal frequency of occurrences and their spatial extents has been dramatically increased. West of Iran, especially in spring and summer, suffers from significant increases of these events which cause several social and economic problems. Detecting and recognizing the extent of dust storms is very important issue in designing warning systems, management and decreasing the risk of this phenomenon. As the process of monitoring and prediction are related to detection of this phenomenon and it's separation from other atmospheric phenomena such as cloud, so the main aim of this research is establishing an automated process for detection of dust masses. In this study 20 events of dust happened in western part of Iran during 2000-2011 have been recognized and studied. To the aim of detecting dust events we used satellite images of MODIS sensor. Finally a model based on reflectance and thermal infrared bands has been developed. The efficiency of this method has been checked using dust events. Results show that the model has a good performance in all cases. It also has the ability and robustness to be used in any dust storm forecasting and warning system.

SELECTION OF CITATIONS
SEARCH DETAIL
...